메뉴 건너뛰기




Volumn 126, Issue 1, 2006, Pages 120-127

An evaluation of thrombophilia screening in an urban tertiary care medical center: A "Real World" experience

Author keywords

Hypercoagulability; Hypercoagulable; Overutilization; Pregnancy; Screening; Stroke; Thromboembolism; Thrombophilia; Thrombosis; Utilization

Indexed keywords

LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

EID: 33745788144     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KV0632LJ8EDMEWQT     Document Type: Article
Times cited : (36)

References (21)
  • 1
    • 18644369163 scopus 로고    scopus 로고
    • Thrombophilia, clinical factors, and recurrent venous thrombotic events
    • Christiansen SC, Cannegieter SC, Koster T, et al. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293:2352-2361.
    • (2005) JAMA , vol.293 , pp. 2352-2361
    • Christiansen, S.C.1    Cannegieter, S.C.2    Koster, T.3
  • 2
    • 23344449367 scopus 로고    scopus 로고
    • Duration of anticoagulation following venous thromboembolism
    • Ost D, Tepper J, Mihara H, et al. Duration of anticoagulation following venous thromboembolism. JAMA. 2005;294:706-715.
    • (2005) JAMA , vol.294 , pp. 706-715
    • Ost, D.1    Tepper, J.2    Mihara, H.3
  • 3
    • 0002181290 scopus 로고    scopus 로고
    • Epidemiology of venous thromboembolism
    • Kearon C. Epidemiology of venous thromboembolism. Semin Vasc Med. 2001;1:7-25.
    • (2001) Semin Vasc Med , vol.1 , pp. 7-25
    • Kearon, C.1
  • 4
    • 0033983988 scopus 로고    scopus 로고
    • High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism
    • Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost. 2000;83:5-9.
    • (2000) Thromb Haemost , vol.83 , pp. 5-9
    • Kraaijenhagen, R.A.1    In'T Anker, P.S.2    Koopman, M.M.3
  • 6
    • 0033028586 scopus 로고    scopus 로고
    • Hyperhomocysteinemia, atherosclerosis and thrombosis
    • Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165-176.
    • (1999) Thromb Haemost , vol.81 , pp. 165-176
    • Cattaneo, M.1
  • 7
    • 0141484369 scopus 로고    scopus 로고
    • The epidemiology of venous thromboembolism in Caucasians and African-Americans: The GATE study
    • Dowling NF, Austin H, Dilley A, et al. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE study. J Thromb Haemost. 2003;1:80-87.
    • (2003) J Thromb Haemost , vol.1 , pp. 80-87
    • Dowling, N.F.1    Austin, H.2    Dilley, A.3
  • 8
    • 0242575182 scopus 로고    scopus 로고
    • Risk factors for venous thrombosis in the black population
    • Patel RK, Ford E, Thumpston J, et al. Risk factors for venous thrombosis in the black population. Thromb Haemost. 2003;90:835-838.
    • (2003) Thromb Haemost , vol.90 , pp. 835-838
    • Patel, R.K.1    Ford, E.2    Thumpston, J.3
  • 9
    • 3142596443 scopus 로고    scopus 로고
    • Screening for hypercoagulable syndromes following stroke
    • Bushnell C, Goldstein LB. Screening for hypercoagulable syndromes following stroke. Curr Atheroscler Rep. 2003;5:291-298.
    • (2003) Curr Atheroscler Rep , vol.5 , pp. 291-298
    • Bushnell, C.1    Goldstein, L.B.2
  • 10
    • 0034279012 scopus 로고    scopus 로고
    • Laboratory test utilization in the diagnosis of hypercoagulability
    • McKenzie SB, Clare CN, Smith LA, et al. Laboratory test utilization in the diagnosis of hypercoagulability. Clin Lab Sci. 2000;13:215-221.
    • (2000) Clin Lab Sci , vol.13 , pp. 215-221
    • McKenzie, S.B.1    Clare, C.N.2    Smith, L.A.3
  • 11
    • 33745775586 scopus 로고    scopus 로고
    • Quest Diagnostics. About Quest Diagnostics Inc. Available at http://www.questdiagnostics.com/brand/index.html. Accessed November 22, 2005.
    • About Quest Diagnostics Inc.
  • 12
    • 84927698388 scopus 로고    scopus 로고
    • The National Alliance for Thrombosis and Thrombophilia. Research page. Available at http://www.nattinfo.org/research. htm. Accessed November 22, 2005.
    • Research Page
  • 13
    • 0035165383 scopus 로고    scopus 로고
    • G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism
    • Miles JS, Miletich JP, Goldhaber SZ, et al. G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol. 2001;37:215-218.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 215-218
    • Miles, J.S.1    Miletich, J.P.2    Goldhaber, S.Z.3
  • 14
    • 0028784353 scopus 로고
    • Factor V Leiden and risks of recurrent idiopathic venous thromboembolism
    • Ridker PM, Miletich JP, Stampfer MJ, et al. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995;92:2800-2802.
    • (1995) Circulation , vol.92 , pp. 2800-2802
    • Ridker, P.M.1    Miletich, J.P.2    Stampfer, M.J.3
  • 15
    • 0031056991 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism in patients with an Arg506→Gln mutation in the gene for factor V (factor V Leiden)
    • Simioni P, Prandoni P, Lensing AWA, et al. The risk of recurrent venous thromboembolism in patients with an Arg506→Gln mutation in the gene for factor V (factor V Leiden). N Engl J Med. 1997;336:399-403.
    • (1997) N Engl J Med , vol.336 , pp. 399-403
    • Simioni, P.1    Prandoni, P.2    Lensing, A.W.A.3
  • 16
    • 0034670050 scopus 로고    scopus 로고
    • Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis
    • Simioni P, Prandoni P, Lensing AWA, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood. 2000;96:3329-3333.
    • (2000) Blood , vol.96 , pp. 3329-3333
    • Simioni, P.1    Prandoni, P.2    Lensing, A.W.A.3
  • 17
    • 0034680013 scopus 로고    scopus 로고
    • High plasma levels of factor VIII and the risk of recurrent venous thromboembolism
    • Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med. 2000;343:457-462.
    • (2000) N Engl J Med , vol.343 , pp. 457-462
    • Kyrle, P.A.1    Minar, E.2    Hirschl, M.3
  • 18
    • 0013131419 scopus 로고    scopus 로고
    • The risk of recurrent venous thromboembolism among patients with high factor IX levels
    • Weltermann A, Eichinger S, Bialonczyk C, et al. The risk of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost. 2003;1:28-32.
    • (2003) J Thromb Haemost , vol.1 , pp. 28-32
    • Weltermann, A.1    Eichinger, S.2    Bialonczyk, C.3
  • 19
    • 0028949953 scopus 로고
    • Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
    • den Heijer M, Blom HJ, Gerrits WBJ, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-885.
    • (1995) Lancet , vol.345 , pp. 882-885
    • Den Heijer, M.1    Blom, H.J.2    Gerrits, W.B.J.3
  • 20
    • 0031754849 scopus 로고    scopus 로고
    • Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
    • Eichinger S, Stümpflen A, Hirschl M, et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost. 1998;80:566-569.
    • (1998) Thromb Haemost , vol.80 , pp. 566-569
    • Eichinger, S.1    Stümpflen, A.2    Hirschl, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.